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As the C-terminal octapeptide of cholecystokinin represents a putative neurotransmitter in the central 
nervous system, the membrane-bound enzymes involved in its inactivation were investigated. Two 
aminopeptidases, involved in the cleavage of enkephalins, and a metalloendopeptidase were identified in 
extracts of solubilized synaptic membranes. The metalloendopeptidase, which cleaves CCK-8 at the 
Trp3’-Met3’ bond, appeared to be indistinguishable from ‘enkephalinase A,’ on the basis of its 
chromatographic behaviour, sensitivity to inhibitors and relative affinities for Met- and Leu-enkephalins. 
This finding indicates that CCK-8 is inactivated in vitro by the same peptidases as enkephalins. 
C-Terminal octapeptide of cholecystokinin Enkephalin Neuropeptidase Enkephalinase A 
Metalloendopeptidase 
1. INTRODUCTION 
The discovery of the gastrointestinal hormone 
cholecystokinin in the brain of mammals [l-5] and 
the growing evidence that its C-terminal octapepti- 
de represents acandidate nemotransmitter (or neu- 
romodulator) in the central nervous system led us 
to search for a specific inactivating enzyme which 
would destroy the peptide after its discharge in the 
synaptic cleft. 
We described hydrolysis of CCK-8 by soluble [6] 
and membrane-bound aminopeptidases [7,8] 
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Solubilized synaptic membrane 
which were previously identified for the cleavage 
of enkephalins [9-111. In addition, we observed 
cleavage of CCK-8 by a metalloendopeptidase 
from solubilized synaptic membranes whose pro- 
perties are reported here. On the basis of its chro- 
matographic behaviour, sensitivity to inhibitors 
and relative affinities for Met- and Leu- 
enkephalins, this enzyme appeared to be indistin- 
guishable from a peptidase which cleaves enkepha- 
lins at the Gly3-Phe4 bond and described as ‘en- 
kephalinase Al’ [10,12,13]. 
2. MATERIALS AND METHODS 
2.1. Peptides and inhibitors 
Synthetic sulfated CCK-8 (SQ 19,844), Capto- 
pril (SQ 14,225) and teprotide (SQ 20,881) were ge- 
nerous gifts from Dr S.J. Lucania (Squibb Institu- 
te for Medical Research, Princeton, NJ). Sulfated 
CCK-7 was supplied by Dr J.S. Morley (ICI, Mac- 
clesfield, UK) and bestatin was a gift of Dr H. 
Umezawa (Institute of Microbial Chemistry, To- 
kyo, Japan). 
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2.2. Separation of the solubilized peptidases 
from rat synaptic membranes 
Fifteen to twenty Wistar rats were decapitated 
and whole brains minus cerebellum and brain stem 
were rapidly dissected. A crude mitochondrial-syn- 
aptosomal pellet (Pz) was prepared by a modifica- 
tion of the Whittaker procedure [14]. The mem- 
brane pellet obtained after a hypotonic shock was 
treated with 1 M KC1 and extensively washed as 
previously described [7]. Solubilization was perfor- 
med according to Gorenstein and Snyder [lo]. The 
solubilized extract was submitted to a DEAE- 
cellulose chromatography as previously described 
]7,81. 
2.3. Analysis of CCK-8 cleavage products by 
HPLC 
CCK-8 or related peptides were incubated for 
varying times at 37°C with the different chromato- 
graphic fractions. The reaction was stopped by 
boiling and the samples were analyzed by HPLC 
on pBondapak columns as previously described 
[7,8] except hat the linear acetonitrile gradient was 
established between 6 and 34070, in a 10 mM am- 
monium acetate buffer (pH 5.1). 
2.4. Amino-terminal sequence analysis 
Three nmol of sample were analyzed by automa- 
ted Edman degradation on a modified Beckman 
sequenator. PTH amino acid derivatives were ana- 
lyzed by HPLC [8]. 
3. RESULTS AND DISCUSSION 
3.1. Separation by DEAE-cellulose chromato- 
graphy of Triton X-100 solubilized CCK-8 
cleaving enzymes 
DEAE fractionation of Triton X-100 solubili- 
zed synaptic membranes revealed at least five dif- 
ferent CCK-8 cleaving enzymes (fig.1). Two ami- 
nopeptidases of broad specificity (peaks III and V) 
gave rise to free tryptophan as the major fluore- 
scent degradation product. These enzymes cleaved 
the N-terminal tyrosine residue of enkephalins 
[lo, 111, the N-terminal tryptophan residue of 
CCK-4 [7] and hydrolyzed sequentially all the pep- 
tide bonds (up to the tryptophan residue) of 
CCK-8 [8]. CCK-8 was converted into its C- 
terminal heptapeptide by two proteases (peaks II 
and IV), one of which corresponded to an amino- 
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Fig. 1. Separation by DEAE-cellulose chromatography 
of Triton X-100 solubilized CCK-8 cleaving enzymes. 
Solubilization was performed by incubating the crude 
synaptic membranes (Pz pellet) for 30 min at 37°C in 
10 vol. 50 mM Tris-HCl buffer (pH 7.7), containing 
1% Triton X-100. After centrifugation, the extract was 
applied to a DEAE-cellulose column (2 x 15 cm) 
equilibrated in the same buffer containing 0.1% Triton 
X-100 and eluted using a linear NaCl gradient from 0 to 
0.28 M [8]. The fractions were incubated with sulfated 
CCK-8 (25 pM final concentration) for 5 h at 37°C and 
the samples were analyzed by reverse-phase HPLC on a 
,uBondapak Cra column, using a linear acetonitrile 
gradient from 6 to 34% [8]. The natural fluorescence of 
tryptophan or of tryptophan-containing peptides was 
monitored at 334 nm; the peaks were integrated and 
quantified using standard fluorescence curves of the 
appropriate peptide. Free tryptophan (o---o) and the 
C-terminal heptapeptide of CCK (x - X) were identified 
on the basis of their retention times as compared with 
standards. A fluorescent fragment with a R, = 11 .O min 
(M) was detected in the void volume. Results 
represent one typical profile out of three. 
peptidase A activity (peak II) as previously descri- 
bed [8]. Eluting in the void volume (fig.1: peak I) 
like ‘enkephalinase Al’ [10,12], another CCK-8 
cleaving activity gave rise to a tryptophan- 
containing fragment with a retention time of 
11 .O min in our HPLC conditions. This fragment 
did not elute like standards of CCK4 (Rt = 
14.8 min), CCK-5 (R, = 15.6 min), CCK-6 (R, = 
17.0 min), unsulfated CCK-7 (Rt = 17.6 min), sul- 
fated CCK-7 (Rt = 15.2 min) or unsulfated CCK-8 
(Rt = 15.0 min). 
3.2. Kinetics of cleavage of CCK-8 by peak I and 
identification of the major fragment 
produced 
Two fluorescent cleavage products were genera- 
ted upon incubation of sulfated CCK-8 with peak 
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I: a major fragment (Rt = 11 .O min) and a minor 
fragment (R, = 9.5 min) whose appearance was not 
linear with time (fig.2). The major cleavage frag- 
ment was collected, repurified by HPLC and sub- 
mitted to N-terminal sequence analysis. The follo- 
wing sequence was found: 
@03H) 
Asp-Tyr-Met-Gly-Trp 
which corresponds to the N-terminal pentapeptide 
of CCK-8. This was confirmed by amino acid 
analysis. 
3.3. Specificity of the enzyme which degraded 
CCK-8 into its N-terminal pentapeptide 
A dose-related inhibition of the cleavage of 
CCK-8 by peak I was observed in the presence of 
Met-enkephalin (ZSO = 25 PM), (D-Ala*)Met- 
enkephalin (ZSO = 33 PM) and Leu-enkephalin 
(ZSO = 120pM) (fig.3). Furthermore this enzyme 
gave rise to the Tyr-Gly-Gly fragment when incu- 
bated with Leu-enkephalin alone (data not shown). 
The relative affinities of this CCK-8 cleaving enzy- 
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To further clarify the nature of the CCK-8 clea- 
ving enzyme which emerged in the void volume 
(enkephalinase A or angiotensin-converting enzy- 
me which cleaved also enkephalins at the 
Gly3-Phe4 bond), we evaluated the effect of a va- 
riety of protease inhibitors. As shown in table 1, 
the cleavage of CCK-8 by peak I was completely 
abolished by 1.5 mM 1, lo-phenanthroline indica- 
ting that the enzyme involved is a metalloprotease. 
This cleavage was also markedly inhibited by the 
dipeptide Tyr-Gly (ZSO = 60 PM) and 0.2 mM phe- 
nobarbital, which are specific enkephalinase A in- 
hibitors, while ACE inhibitors, tested at high con- 
centrations exerted a moderate inhibitory effect. 
Fig.2. Kinetics of cleavage of CCK-8 by peak I. 
Incubation of sulfated CCK-8 (final concentration 
SOpM) at 37°C with peak I gave rise to a major 
fluorescent degradation product with a retention time of 
11.0 min (M) and a minor fragment with a 
retention time of 9.5 min (M). Bestatin (100,~M) 
was included in the assay medium to inhibit 
contaminating aminopeptidase activity. 50 pM p-hydroxymercuribenzoate did not signi- 
-5 -4 
[ENKEPHALIN] ( log M ) 
Fig.3. Dose-inhibition curves of enkephalins on the 
hydrolysis of CCK-8 by peak I. Sulfated CCK-8 (final 
concentration 25 PM) was incubated for 5 h at 37°C 
with increasing concentrations of Met-enkephalin 
(m), (D-Ala*)-Met-enkephalin (A--A) or Leu- 
enkephalin (M) in the presence of 100 ,uM bestatin. 
The degradation products were separated by reverse- 
phase HPLC as described in section 2. The N-terminal 
fragment of CCK-8 (& = 11 .O min) was quantified and 
expressed in percentage of the amount which appeared 
in the absence of added enkephalins. Results are the 
mean of two experiments made in duplicate. 
me for Met- and Leu-enkephalin corresponded to 
the specificity of enkephalinase A described by 
Snyder [10,12] and others [15]. The cleavage of 
CCK-8 was also inhibited by other neuropeptides 
including neurotensin, physalaemin and angioten- 
sin II (data not shown). 
3.4. Effects of inhibitors on the cleavage of 
CCK-8 into its N-terminal pentapeptide 
111 
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Table 1 
Effect of inhibitors on the cleavage of CCK-8 
by peak I 
Inhibitor Concentration N-terminal 
(mM) fragment (in % of 
control) 
Control 0 100 
Tyr-Gly 0.01 100 
0.03 12 
0.1 32 
0.3 I 
Phenobarbital 0.2 52 
Captopril 1.0 66 
SQ 20,881 0.01 86 
1, IO-Phen- 
anthroline 1.5 0 
PHMB 0.05 91 
OtM) 
Phosphoramidon 0.01 81 
0.03 43 
0.03 9 
Sulfated CCK-8 was incubated at a 25 ,uM concentration 
for 5 h at 37°C with peak I, in the presence of 100 ,uM 
bestatin and in the absence or presence of various 
inhibitors. Results are the mean of two experiments 
made in duplicate 
ficantly influence activity. The inhibitory spectrum 
of the enzyme that cleaved CCK-8 into its N- 
terminal pentapeptide corresponded to what has 
been described by many groups for enkephalinase 
A [10,12,13,15]. Furthermore, the powerful inhibi- 
tion exerted by phosphoramidon (ZSO = 23 nM), an 
inhibitor of thermolysin [16] and membrane- 
bound metalloendopeptidases [ 15,171, as well as 
the nature of the CCK-8 fragment produced (clea- 
vage of the Trp3’-Met31 bond) indicated that this 
enzyme is in fact a metalloendopeptidase. 
Almenoff et al. [18] and others more recently 
[ 191 have raised the question of the identity of a pi- 
tuitary membrane-bound metalloendopeptidase 
and of a similar enzyme from kidney membranes 
[20], with the synaptic membrane-bound enzyme 
which cleaves enkephalins at the Gly3-Phe4 bond. 
3.5. Determination of the kinetic parameters of 
the metalloendopeptidase for the cleavage of 
CCK-8 
The production of the N-terminal pentapeptide 
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of CCK-8 by the metalloendopeptidase obeyed 
Michaelis-Menten kinetics and a K, of 66 ,uM was 
calculated for the cleavage of sulfated CCK-8. Ki 
values of Met-e;kephalin and Leu-enkephalin 
were determined from the ZSO (fig.3) assuming a 
competitive inhibition of CCK-8 cleavage. Values 
of 17 ,uM and 85 PM were found respectively, 
which are in agreement with the Ki of 10pM 
reported for Met-enkephalin hydrolysis by 
solubilized enkephalinase A [IO] and with the K,,, 
of 78-79pM determined by Rush and Hersh [21] 
for Leu-enkephalin cleavage by enkephalinase Al. 
The discrepancy observed between these values 
and those determined with synaptic membranes 
may result from the assay conditions (solubiliza- 
tion by Triton X-100, alkaline medium). 
The Max of the solubilized metalloendopeptid- 
ase for sulfated CCK-8 cleavage was 
44.0 pmol/min/assay as compared to values of 
27.4 pmol/min/assay for Met-enkephalin and 
62.5 pmol/min/assay for Leu-enkephalin. These 
results indicate that, in vitro, the affinity of enkep- 
halinase A and its rate of cleavage of CCK-8, are 
of the same order of magnitude as the kinetic para- 
meters determined for Met- and Leu-enkephalins 
degradation. 
3.6. Influence of the N-terminal region of CCK-8 
on the rate of hydrolysis of the Trp30-Met3’ 
bond by the metalloendopeptidase 
Figure 4 represents the kinetics of appearance of 
the N-terminal fragments of sulfated and unsulfa- 
ted CCK-7 and -8. It is obvious that the presence 
of the negatively charged sulfate group enhanced 
the rate of cleavage of the peptide as compared to 
its unsulfated form. The presence of the N- 
terminal aspartic residue in the octapeptide increa- 
sed also the rate of cleavage of the Trp-Met bond, 
as seen from the comparison between sulfated 
CCK-7 and -8 as well as between unsulfated CCK-7 
and -8. 
In conclusion, it appears that the C-terminal oc- 
tapeptide of cholecystokinin is inactivated by three 
synaptic membrane-bound enzymes also involved 
in the cleavage of enkephalins: two aminopeptida- 
ses ([8] and fig. 1) and a metalloendopeptidase pre- 
viously described as ‘enkephalinase Ai’ [lo]. A 
dipeptidyl-carboxypeptidase activity as originally 
described in [22] was not detected for the cleavage 
of CCK-8. 
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Fig.4. Kinetics of cleavage of CCK-8 related peptides by 
peak I. Sulfated CCK-8 (o--+), unsulfated CCK-8 
(M), sulfated CCK-7 (s) or unsulfated CCK-7 
(ti) were incubated at a 25 PM final concentration 
for varying times at 37°C in the presence of 1OOpM 
bestatin. Their N-terminal fragments were quantified. 
Results are the mean of two experiments made in 
duplicate. 
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